Letter #1 Response to letter to Editor by Dr. Sarkar et al. for' who said differentiating preeclampsia from COVID-19 infection was easy? Refers to PII: S2210-7789(21)00539-0 Letter #2 Response to letter to Editor by Dr. Hantoushzadeh et al. for' is COVID-19 disease a risk factor for preeclampsia? Should aspirin be considered for prophylaxis of preeclampsia in these patients?' Refers to PII: S2210-7789(21)00538-9.
作者信息
Jayaram A, Buhimschi I A, Buhimschi C S
机构信息
Department of Obstetrics & Gynecology, University of Illinois at Chicago College of Medicine, 820 S. Wood, St. Chicago, IL 60612, United States.
Department of Obstetrics & Gynecology, University of Illinois at Chicago College of Medicine, 820 S. Wood, St. Chicago, IL 60612, United States.
出版信息
Pregnancy Hypertens. 2022 Mar;27:94-95. doi: 10.1016/j.preghy.2021.11.002. Epub 2021 Nov 25.
PMID:34973599
Abstract
摘要
相似文献
[2]
Letter to the Editor Re: Who said differentiating preeclampsia from COVID-19 infection was easy?
Pregnancy Hypertens. 2022-3
[3]
[4]
[5]
Preeclampsia and COVID-19: results from the INTERCOVID prospective longitudinal study.
Am J Obstet Gynecol. 2021-9
[6]
Letter to the Editor: THE IMPACT OF THE COVID-19 PANDEMIC ON SCHIZOPHRENIA PATIENTS.
Turk Psikiyatri Derg. 2021
[7]
[8]
Who said differentiating preeclampsia from COVID-19 infection was easy?
Pregnancy Hypertens. 2021-12
[9]
Preeclampsia and the crucial postpartum period for Covid-19 infected mothers: A case report.
Pregnancy Hypertens. 2021-3
Zotero 插件